Trinity Biotech (TRIB) Goodwill & Intangibles (2009 - 2025)

Trinity Biotech has disclosed Goodwill & Intangibles across 17 years of filings, most recently posting $57.0 million for Q4 2025.

• Goodwill & Intangibles for Q4 2025 came in at $57.0 million, up 10.99% year-over-year; the trailing twelve-month figure through Dec 2025 was $57.0 million (up 10.99% YoY), and the FY2025 annual result was $57.0 million, up 10.99% from the prior year.
• Goodwill & Intangibles came in at $57.0 million for Q4 2025 at Trinity Biotech, up from $55.9 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $57.0 million in Q4 2025 to a low of $15.8 million in Q2 2023.
• The 5-year median for Goodwill & Intangibles is $36.6 million (2021), against an average of $36.0 million.
• Across the five-year window, Goodwill & Intangibles sank 59.33% in 2023 and jumped 215.57% in 2024, its largest moves.
• Trinity Biotech's Goodwill & Intangibles stood at $36.0 million in 2021, then fell by 1.98% to $35.3 million in 2022, then plunged by 53.87% to $16.3 million in 2023, then surged by 215.57% to $51.3 million in 2024, then gained by 10.99% to $57.0 million in 2025.
• The last three Goodwill & Intangibles figures came in at $57.0 million (Q4 2025), $55.9 million (Q2 2025), and $51.3 million (Q4 2024), per Business Quant data.